DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Rubinger M, Lillicrap D, Rivard GE , et al; Association of Hemophilia Clinic Directors of Canada.
A prospective surveillance study of factor VIII inhibitor development in the Canadian haemophilia A population following the switch to a recombinant factor VIII product formulated with sucrose.
Haemophilia 2008;
14 (2) 281-286
We do not assume any responsibility for the contents of the web pages of other providers.